Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;43(1):577-584.
doi: 10.1080/0886022X.2021.1901740.

Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests

Fabiola Sanchez-Meza  1 , Aldo Torre  2 , Lilia Castillo-Martinez  3 , Sofia Sanchez-Roman  4 , Luis Eduardo Morales-Buenrostro  1
Affiliations

Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests

Fabiola Sanchez-Meza et al. Ren Fail. 2021 Dec.

Abstract

Background: Uremic encephalopathy is defined as cerebral dysfunction due to toxin accumulation in patients with chronic kidney disease (CKD). This condition is characterized by subtle to florid symptoms, and its clinical course is always progressive when untreated but partially reversible with renal replacement therapy. While no test exists to measure subclinical uremic encephalopathy, two tests have been validated to measure minimal hepatic encephalopathy: the critical flicker frequency (CFF) test and the psychometric hepatic encephalopathy score (PHES).

Objective: To use CFF and PHES to measure the prevalence of cerebral dysfunction in individuals with CKD.

Methods: This cross-sectional study included a total of 69 patients with stage-5 CKD. Cutoff points for minimal encephalopathy were established using existing clinical guidelines: ≤39 Hz for CFF and < -4 for PHES. All participants were also screened for cognitive function and depression.

Results: Eighteen cases (26.1%) of cerebral dysfunction linked to uremic encephalopathy were detected with CFF, while twelve (17.4%) were detected by PHES; only six cases (8.7%) were diagnosed by both methods. Half of the cases (50%) had diabetes, and 61% were on hemodialysis. Cognitive function scores did not differ significantly between those receiving dialysis, hemodialysis, or no renal replacement therapy.

Conclusions: It is essential to identify cerebral dysfunction when uremic encephalopathy is in early subclinical stages to reduce preventable events as traffic and work accidents.

Keywords: Critical flicker frequency; cerebral dysfunction; chronic kidney failure; uremia; uremic encephalopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Prevalence of cerebral dysfunction. Note: [PHES: p 0.004, Flicker p = 0.002]. CKD: chronic kidney disease; PHES: Psychometric Hepatic Encephalopathy Score; CFF: critical flicker frequency.
Figure 2.
Figure 2.
Correlation between PHES and CFF scores and severity of depression by Beck Depression Inventory. *Cerebral dysfunction; PHES: Psychometric Hepatic Encephalopathy Score; CFF: critical flicker frequency.
Figure 3.
Figure 3.
Changes in CFF pre- and post-hemodialysis.
See this image and copyright information in PMC

References

    1. Levin A, Tonelli M, Bonventre J, et al. . Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1830–1888. - PubMed
    1. Burn DJ, Bates D.. Neurology and the kidney [Review]. J Neurol Neurosurg Psychiatry. 1998;65:810–821. - PMC - PubMed
    1. Olano CG, Akram SM, Bhatt H.. Uremic encephalopathy. Treasure Island (FL): StatPearls Publishing; 2021. - PubMed
    1. Vanholder R, De Smet R, Glorieux G, et al. , For the European Uremic Toxin Work Group (EUTox) . Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63:1934–1943. - PubMed
    1. Kim DM, Lee IH, Song CJ. Uremic encephalopathy: MR imaging findings and clinical correlation. Am J Neuroradiol. 2016;37(9):1604–1609. - PMC - PubMed

LinkOut - more resources